Cathelicidin-related peptide, Oh-Cath

General Information


DRACP ID  DRACP03569

Peptide Name   Cathelicidin-related peptide, Oh-Cath

Sequence  KFFKKLKNSVKKRAKKFFKKPRVIGVSIPF

Sequence Length  30

UniProt ID  B6S2X2 

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03569

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C175H289N47O34

Absent amino acids  CDEHMQTWY

Common amino acids  K

Mass  411293

Pl  12.63

Basic residues  12

Acidic residues  0

Hydrophobic residues  12

Net charge  12

Boman Index  -5425

Hydrophobicity  -51.67

Aliphatic Index  71.33

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24637683

Title  Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis

Doi Not available

Year  2014

Literature 2

Pubmed ID 20576537

Title  Structure-function relationship of king cobra cathelicidin

Doi Not available

Year  2010

Literature 3

Pubmed ID 22491685

Title  Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  7699

DRACP is developed by Dr.Zheng's team.